Literature DB >> 26315210

A review of guidance on immunization in persons with defective or deficient splenic function.

Ernest Kuchar1,2, Katarzyna Miśkiewicz1, Monika Karlikowska1.   

Abstract

The spleen acts as a blood filter and lymphopoietic organ. Asplenic and hyposplenic individuals are more susceptible to serious infections caused by encapsulated bacteria but they can be protected by antibiotic prophylaxis and immunizations. Recent progress in vaccinology means prophylaxis is now successful in the vast majority of serious infections with pneumococci, meningococci and Haemophilus influenzae type b responsible for the majority of cases of overwhelming sepsis in asplenic patients. Current guidelines are coherent. Physicians treating patients with conditions associated with hyposplenism are ethically obliged to immunize their patients using the vaccines currently available to protect them from largely preventable, life-threatening infections.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  asplenia; immunocompromised; sickle cell disease; splenectomy; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26315210     DOI: 10.1111/bjh.13660

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.

Authors:  Antonio Di Sabatino; Marco Vincenzo Lenti; Francesco Paolo Tinozzi; Marina Lanave; Ivana Aquino; Catherine Klersy; Piero Marone; Carlo Marena; Andrea Pietrabissa; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2017-08-10       Impact factor: 3.397

Review 4.  Atypical Hemolytic Uremic Syndrome: A Brief Review.

Authors:  Kuixing Zhang; Yuxin Lu; Kevin T Harley; Minh-Ha Tran
Journal:  Hematol Rep       Date:  2017-06-01

5.  A cohort study to evaluate infection prevention protocol in pediatric trauma patients with blunt splenic injury in a Dutch level 1 trauma center.

Authors:  Roy Spijkerman; Michel Pj Teuben; Falco Hietbrink; William Lm Kramer; Luke Ph Leenen
Journal:  Patient Prefer Adherence       Date:  2018-08-28       Impact factor: 2.711

Review 6.  OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Authors:  Nicola Cotugno; Alessandra Ruggiero; Veronica Santilli; Emma Concetta Manno; Salvatore Rocca; Sonia Zicari; Donato Amodio; Manuela Colucci; Paolo Rossi; Ofer Levy; Federico Martinon-Torres; Andrew J Pollard; Paolo Palma
Journal:  J Immunol Res       Date:  2019-04-28       Impact factor: 4.818

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

8.  [Invasive pneumococcal infection prevention in asplenic patients].

Authors:  J Rodríguez-García; R Fernández-Santos; E Ruiz de Gopegui-Bordes; O Hidalgo-Pardo
Journal:  Rev Esp Quimioter       Date:  2020-01-03       Impact factor: 1.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.